SODELGLITAZAR

Details

Stereochemistry	ACHIRAL
Molecular Formula	C23H21F4NO3S2
Molecular Weight	499.541
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CC1=C(CSC2=CC=C(OC(C)(C)C(O)=O)C(C)=C2)SC(=N1)C3=CC=C(C=C3F)C(F)(F)F

InChI

InChIKey=ZUGQWAYOWCBWGM-UHFFFAOYSA-N

InChI=1S/C23H21F4NO3S2/c1-12-9-15(6-8-18(12)31-22(3,4)21(29)30)32-11-19-13(2)28-20(33-19)16-7-5-14(10-17(16)24)23(25,26)27/h5-10H,11H2,1-4H3,(H,29,30)

HIDE SMILES / InChI

Molecular Formula	C23H21F4NO3S2
Molecular Weight	499.541
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Description
Sources: https://adisinsight.springer.com/drugs/800018093 | https://www.ncbi.nlm.nih.gov/pubmed/21592078 | https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=NCI_Thesaurus&code=C75193

Sodelglitazar is an oral insulin sensitiser, a peroxisome proliferator-activated receptor (PPAR) pan agonist that was under development with GlaxoSmithKline for the treatment of hyperlipidaemia, type 2 diabetes mellitus and metabolic syndrome. Sodelglitazar exerts higher binding affinity for the delta subtype as compared to gamma and alpha subtypes. Sodelglitazar was being investigated in Phase II clinical trials for the treatment of T2DM and its complications, but this research has been discontinued.

Originator

Approval Year

Targets

Primary Target	Pharmacology	Condition	Potency
Peroxisome proliferator-activated receptor 5 Target ID: CHEMBL3559683 Sources: https://www.ncbi.nlm.nih.gov/pubmed/21592078	Agonist 2678

PubMed

Title	Date	PubMed

Patents

Sample Use Guides

In Vivo Use Guide

Type 2 Diabetes Mellitus: oral capsules (15 mg)

Route of Administration: Oral

Substance Class	Chemical Created by `admin` on `Fri Dec 15 16:24:34 GMT 2023` Edited by `admin` on `Fri Dec 15 16:24:34 GMT 2023`
Record UNII	6G973E04VI
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

SODELGLITAZAR

Official Name

English

GW677954

Code

English

2-[4-[[[2-[2-Fluoro-4-(trifluoromethyl)phenyl]-4-methyl-1,3-thiazol-5-yl]methyl]sulfanyl]-2-methylphenoxy]-2-methylpropanoic acid

Systematic Name

English

GW-677954

Code

English

SODELGLITAZAR [USAN]

Common Name

English

sodelglitazar [INN]

Common Name

English

Classification Tree Code System Code

NCI_THESAURUS

C98233